| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |